2019年33种细菌病原体相关的全球死亡率:全球疾病负担研究2019的系统分析
该研究基于全球疾病负担研究(GBD)2019方法,估算2019年204个国家中33种细菌病原体在11种感染综合征中相关的死亡数。2019年估计有1370万例感染相关死亡,其中770万例(95%不确定区间5.7–10.2百万)与33种细菌病原体相关,占全球全因死亡的13.6%(10.2–18.1)、脓毒症相关死亡的56.2%(52.1–60.1)。金黄色葡萄球菌、大肠埃希菌、肺炎链球菌、肺炎克雷伯菌和铜绿假单胞菌五种病原体占所调查细菌相关死亡的54.9%(52.9–56.9)。作者认为,与GBD三级根本死因相比,这些细菌相关死亡将位列2019年全球第二大死因,应作为全球卫生的紧急干预优先事项。
要点
- 2019年全球770万例死亡(95% UI 5.7–10.2百万)与33种细菌病原体相关,占全因死亡的13.6%(10.2–18.1)。
- 这33种细菌相关死亡占2019年所有脓毒症相关死亡的56.2%(52.1–60.1)。
- 金黄色葡萄球菌、大肠埃希菌、肺炎链球菌、肺炎克雷伯菌和铜绿假单胞菌五种病原体占所调查细菌相关死亡的54.9%(52.9–56.9)。
- 5岁以下儿童中,肺炎链球菌是相关死亡最多的病原体;15岁以上人群中,金黄色葡萄球菌相关死亡最多。
- 下呼吸道感染和血流感染各导致超过200万例死亡,腹膜和腹腔内感染导致超过100万例死亡。
适用人群与场景
- 2019年全球204个国家和地区的全年龄段男性和女性。
研究设计与关键结果
- 研究类型:基于GBD 2019方法的系统分析,纳入343百万条个体记录或分离株,覆盖11 361个研究地点-年份。
- 2019年估计有1370万例(95% UI 10.9–17.1百万)感染相关死亡,其中770万例(5.7–10.2百万)与33种细菌病原体相关。
- 33种细菌病原体相关死亡占全球全因死亡的13.6%(10.2–18.1),占脓毒症相关死亡的56.2%(52.1–60.1)。
- 五种主要病原体(金黄色葡萄球菌、大肠埃希菌、肺炎链球菌、肺炎克雷伯菌、铜绿假单胞菌)占所调查细菌相关死亡的54.9%(52.9–56.9)。
- 年龄标化死亡率最高为撒哈拉以南非洲超级区域,每10万人口230例死亡(185–285);最低为高收入超级区域,每10万人口52.2例死亡(37.4–71.5)。
- 金黄色葡萄球菌是135个国家细菌相关死亡的首位原因,也是全球15岁以上人群相关死亡最多的病原体;5岁以下儿童中肺炎链球菌相关死亡最多。
- 2019年三种细菌感染综合征导致超过600万例死亡:下呼吸道感染和血流感染各超过200万例,腹膜和腹腔内感染超过100万例。
证据类型、等级与局限
- 证据类型:基于GBD 2019方法的系统分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,与GBD三级根本死因相比,这33种细菌相关死亡将位列2019年全球第二大死因,应作为全球卫生的紧急干预优先事项。
- 作者提出的应对策略包括感染预防、优化抗生素使用、提升微生物分析能力、疫苗开发以及改进和更广泛地使用现有疫苗。
- 作者认为,这些估计可用于帮助确定疫苗需求、需求和开发的优先事项。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Reducing the burden of death due to infection is an urgent global public health priority. Previous studies have estimated the number of deaths associated with drug-resistant infections and sepsis and found that infections remain a leading cause of death globally. Understanding the global burden of common bacterial pathogens (both susceptible and resistant to antimicrobials) is essential to identify the greatest threats to public health. To our knowledge, this is the first study to present global comprehensive estimates of deaths associated with 33 bacterial pathogens across 11 major infectious syndromes.
METHODS: We estimated deaths associated with 33 bacterial genera or species across 11 infectious syndromes in 2019 using methods from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, in addition to a subset of the input data described in the Global Burden of Antimicrobial Resistance 2019 study. This study included 343 million individual records or isolates covering 11 361 study-location-years. We used three modelling steps to estimate the number of deaths associated with each pathogen: deaths in which infection had a role, the fraction of deaths due to infection that are attributable to a given infectious syndrome, and the fraction of deaths due to an infectious syndrome that are attributable to a given pathogen. Estimates were produced for all ages and for males and females across 204 countries and territories in 2019. 95% uncertainty intervals (UIs) were calculated for final estimates of deaths and infections associated with the 33 bacterial pathogens following standard GBD methods by taking the 2·5th and 97·5th percentiles across 1000 posterior draws for each quantity of interest.
FINDINGS: From an estimated 13·7 million (95% UI 10·9-17·1) infection-related deaths in 2019, there were 7·7 million deaths (5·7-10·2) associated with the 33 bacterial pathogens (both resistant and susceptible to antimicrobials) across the 11 infectious syndromes estimated in this study. We estimated deaths associated with the 33 bacterial pathogens to comprise 13·6% (10·2-18·1) of all global deaths and 56·2% (52·1-60·1) of all sepsis-related deaths in 2019. Five leading pathogens-Staphylococcus aureus, Escherichia coli, Streptococcus pneumoniae, Klebsiella pneumoniae, and Pseudomonas aeruginosa-were responsible for 54·9% (52·9-56·9) of deaths among the investigated bacteria. The deadliest infectious syndromes and pathogens varied by location and age. The age-standardised mortality rate associated with these bacterial pathogens was highest in the sub-Saharan Africa super-region, with 230 deaths (185-285) per 100 000 population, and lowest in the high-income super-region, with 52·2 deaths (37·4-71·5) per 100 000 population. S aureus was the leading bacterial cause of death in 135 countries and was also associated with the most deaths in individuals older than 15 years, globally. Among children younger than 5 years, S pneumoniae was the pathogen associated with the most deaths. In 2019, more than 6 million deaths occurred as a result of three bacterial infectious syndromes, with lower respiratory infections and bloodstream infections each causing more than 2 million deaths and peritoneal and intra-abdominal infections causing more than 1 million deaths.
INTERPRETATION: The 33 bacterial pathogens that we investigated in this study are a substantial source of health loss globally, with considerable variation in their distribution across infectious syndromes and locations. Compared with GBD Level 3 underlying causes of death, deaths associated with these bacteria would rank as the second leading cause of death globally in 2019; hence, they should be considered an urgent priority for intervention within the global health community. Strategies to address the burden of bacterial infections include infection prevention, optimised use of antibiotics, improved capacity for microbiological analysis, vaccine development, and improved and more pervasive use of available vaccines. These estimates can be used to help set priorities for vaccine need, demand, and development.
FUNDING: Bill & Melinda Gates Foundation, Wellcome Trust, and Department of Health and Social Care, using UK aid funding managed by the Fleming Fund.
参考来源
- Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022. PMID: 36423648. doi:10.1016/S0140-6736(22)02185-7
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。